Helping patients find the colon cancer
resources they deserve
How do we help colon cancer patients?
Massive Bio offers an independent cancer treatment analysis as well as clinical trial matching for colon cancer patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.
We can also provide a comprehensive case analysis through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.
There are approximately 925 clinical trials across the United States for colon cancer. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence-based clinical trial matching system will find the best option for you.
With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.
Colon Cancer Facts
When combining men and women, colon cancer, also referred to as colorectal cancer, has the second most deaths annually of any cancer type. Total treatment costs for colon cancer patients is estimated to be about $8.4 billion per year. Today, the five-year survival rate for colon cancer patients is roughly 65%. Obesity increases someone’s risk of colon cancer by nearly 30%. The most common warning sign for colon cancer is a change in bowel movements and wieght loss occuring unexpectedly.
25% of colon cancer patients have a family history of the disease. Like many other cancer types, chances of being diagnosed with colon cancer increase when people regularly smoke cigarettes and drink multiple alcoholic beverages a day. Men are slightly more prone to colon cancer than women. In terms of nationality, African Americans have the highest occurrence rate of any race. Age is the biggest factor for patients. Almost 91% of colon cancer cases are in patients over the age of 50.
The common forms of treatment for colon cancer include chemotherapy, radiofrequency ablation, and immunotherapy. The most common treatment method is surgery. In early stages of the cancer, doctors can perform surgery without cutting through the abdominal wall. If the cancer has progressed, doctors will have to remove a small portion of the colon and sew the remaining sections back together. If the removed section is too large, doctors will have to perform a colostomy so waste can pass through the body.
Over 1 in 3 people are not up-to-date with colon cancer screenings. It is recommended that men and women should begin screening specifically for colon cancer at the age of 50. There are even inexpensive test methods that can be performed at home. The most common screening method is a fecal occult blood test (FOBT), which takes a sample of stool under a microscope to look for any blood. Blood can be a sign of precancers or polyps. Also, colonoscopies are a popular screening method that many men already should be regularly scheduling.
It is estimated that there will be nearly 150,000 new cases in the year 2020. The number of cases in 1975 was 59.5 cases per 100,000 people. More recently in 2016, the number of cases has decreased considerably to 36.7 per 100,000 people. Despite the number of cases decreasing over the last 24 years, the number of deaths has decreased at a less significant rate. In 1975, the death rate was 28.1 deaths per 100,000 people. In 2016, the rate remained at 13.7 deaths per 100,000 people.
Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.